Selected Grants
Outcome Measures for DMD Drug Trials Fixed Rate
ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2024 - 2028Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2024 - 2028CISA 2023 Clinical Contributing Task 2
ResearchInvestigator · Awarded by Centers for Disease Control and Prevention · 2023 - 2028CISA 2023 Clinical Contributing Task 1
ResearchInvestigator · Awarded by Centers for Disease Control and Prevention · 2023 - 2028Development of a Multimodal Biomaker Platform for Predictive Risk Stratification of Cardiac Disease in Duchenne Muscular Dystrophy
ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2025 - 2026CISA Consult 2022 Contributing Task 3
Clinical TrialInvestigator · Awarded by Centers for Disease Control and Prevention · 2022 - 2023External Relationships
- Centers for Disease Control and Prevention
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.